ArticleJournal of cancer research and clinical oncology2014

The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer.

Sung Hoon Sim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.